AB Sciex Expands Operations in Singapore
AB Sciex (Massachusetts, USA) has announced further expansion of its presence in Singapore, with the opening of a new research and development (R&D) centre. The centre is an addition to the company?s existing $10 million manufacturing operations in Marsiling, Singapore.
AB Sciex (Massachusetts, USA) has announced further expansion of its presence in Singapore, with the opening of a new research and development (R&D) centre. The centre is an addition to the company’s existing $10 million manufacturing operations in Marsiling, Singapore.
The centre is focused on bringing R&D and manufacturing together. The company has also invested in an application support and training facility in the “Biopolis” — Singapore’s biomedical research hub of public and private research activity. On the production side, manufacturing of selected chromatography products has already been transferred from the United States to Singapore.
Ms Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board, said: “We are excited about the opening of AB Sciex’s R&D Centre in Singapore ‒ its first R&D centre outside North America. The centre will design and develop new instruments from Singapore for global markets. This is an excellent example of how leading life science tools companies such as AB Sciex are looking to Singapore as an integrated home in Asia for complex instrument manufacturing [and] headquarter functions as well as R&D to support their future growth.”
Rainer Blair, President of AB Sciex, said: “Our significant investments in research and development, manufacturing, and personnel reaffirm our commitment to Singapore as a hub for AB Sciex global operations.” He added: “As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science.”
For more information please visit www.absciex.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
